Limited Offer
Substance Use Disorders, An Issue of Medical Clinics of North America
- 1st Edition, Volume 106-1 - November 29, 2021
- Editor: Melissa B. Weimer
- Language: English
- Hardback ISBN:9 7 8 - 0 - 3 2 3 - 8 4 8 7 6 - 3
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 8 4 8 7 7 - 0
In this issue of Medical Clinics, guest editor Melissa B. Weimer brings her considerable expertise to the topic of Substance Use Disorders.… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteIn this issue of Medical Clinics, guest editor Melissa B. Weimer brings her considerable expertise to the topic of Substance Use Disorders.
- Provides in-depth, clinical reviews on the latest updates in Substance Use Disorders, providing actionable insights for clinical practice.
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field; Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.
- Cover image
- Title page
- Table of Contents
- Copyright
- CME: Accreditation Page
- Forthcoming Issues
- Contributors
- Foreword
- Preface
- What Is Addiction? History, Terminology, and Core Concepts
- Key points
- History
- Controversies and definitions
- Research
- Diagnosis considerations
- Discussion
- Summary
- Clinics care points
- Disclosure
- Sidebar
- Screening for Unhealthy Alcohol and Drug Use in General Medicine Settings
- Key points
- Introduction
- Discussion
- Screening tools for medical settings
- Summary
- Clinics care points
- Disparities in Addiction Treatment: Learning from the Past to Forge an Equitable Future
- Key points
- History of addiction policies in the United States
- Structural racism leading to disparities in addiction
- Structural competency: a patient-centered approach to addiction treatment
- Building diversity as a tool to minimizing disparities in addiction treatment
- Summary
- The Spectrum of Alcohol Use: Epidemiology, Diagnosis, and Treatment
- Key points
- Definitions/epidemiology
- Neurobiology
- Alcohol biomarkers
- Alcohol withdrawal management
- Medical and psychiatric complications
- Medications for alcohol use disorder
- Behavioral treatment
- New advances in treatment
- Summary
- Clinics care points
- Current Best Practices for Acute and Chronic Management of Patients with Opioid Use Disorder
- Key points
- Epidemiology
- Withdrawal management
- Medical and psychiatric complications of opioid use
- Conclusions
- Clinics care points
- Disclosure statement
- Understanding Stimulant Use and Use Disorders in a New Era
- Key points
- Epidemiology
- Pharmacology
- Summary
- Clinics care points
- Funding
- Disclosures
- Tobacco Use Disorder
- Key points
- Introduction
- Transition to modern era tobacco use disorder
- Epidemiology of tobacco use disorder
- Neurobiology of tobacco use disorder
- Pharmacologic treatment of tobacco use disorder
- Discussion
- Clinics care points
- Funding
- Disclosure statement
- Benzodiazepines and Related Sedatives
- Key points
- History and epidemiology of sedatives
- Neurobiology
- Pharmacology
- Physiologic dependence and withdrawal symptoms
- Discontinuation and withdrawal management
- Behavioral treatments for benzodiazepine discontinuation
- Postacute withdrawal syndrome
- Adverse effects and other complications
- Sedatives in combination with other substances
- Clinics care points
- Disclosure
- Clinical Approaches to Cannabis: A Narrative Review
- Key points
- Introduction
- Background
- Epidemiology
- Cannabis pharmacology and neurobiology
- Medical cannabis
- Summary
- Clinics care points
- Prevention of Substance Use Disorders
- Key points
- Introduction
- Adolescent substance use
- Primary prevention for adolescents
- Secondary prevention for adolescents
- Tertiary prevention
- Clinics care points
- Novel preventive interventions
- Summary
- Perioperative Buprenorphine Management: A Multidisciplinary Approach
- Key points
- Case presentation
- Introduction
- Summary
- Clinics care points
- Attribution
- Infectious Complications of Injection Drug Use
- Key points
- Introduction
- Pathogenesis of infections
- Clinical syndromes
- Models of antimicrobial treatment
- Recommended testing and interventions for patients who present with infectious complications of injection drug use
- Summary
- Clinics care points
- Harm Reduction in Health Care Settings
- Key points
- Introduction to harm reduction
- Patient perspectives
- Opioid use
- Infection prevention
- Human immunodeficiency virus prevention: preexposure prophylaxis
- Opioid overdose prevention
- Pain management in the hospital
- Harm reduction for alcohol use
- Managed alcohol programs
- Harm reduction for stimulant use
- Clinical care points: stimulant use
- General harm reduction approaches
- Summary
- Clinics care points
- Gender Dynamics in Substance Use and Treatment: A Women’s Focused Approach
- Key points
- Introduction
- Sex, gender, and the intersectionality of race
- The biopsychosocial model of addiction
- Barriers to addiction and harm reduction services
- Facilitators to addiction treatment and harm reduction services
- Substance use among pregnant and parenting women
- Gender-responsive addiction care
- Summary
- No. of pages: 240
- Language: English
- Edition: 1
- Volume: 106-1
- Published: November 29, 2021
- Imprint: Elsevier
- Hardback ISBN: 9780323848763
- eBook ISBN: 9780323848770
MW
Melissa B. Weimer
Affiliations and expertise
Assistant Professor of Medicine, Yale University General Internal Medicine, Medical Director, Yale Addiction Medicine Consult Service (YAMCS), Yale New Haven Hospital, Associate Program Director, Yale Addiction Medicine Fellowship Program